This topic contains a solution. Click here to go to the answer

Author Question: Elderly patients who are started on levothyroxine for thyroid replacement should be monitored for: ... (Read 55 times)

jparksx

  • Hero Member
  • *****
  • Posts: 570
Elderly patients who are started on levothyroxine for thyroid replacement should be monitored for:
 
  1. Excessive sedation
  2. Tachycardia and angina
  3. Weight gain
  4. Cold intolerance

Question 2

Besides osteoporosis, IV bisphosphonates are also indicated for:
 
  1. Paget's Disease
  2. Early osteopenia
  3. Renal cancer
  4. Early closure of cranial sutures



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Brenm

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

2

Answer to Question 2

1




jparksx

  • Member
  • Posts: 570
Reply 2 on: Jul 24, 2018
Great answer, keep it coming :)


hramirez205

  • Member
  • Posts: 345
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library